Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Contribution of the MLH1 -93G>A Promoter Polymorphism in Modulating Susceptibility Risk in Malaysian Colorectal Cancer Patients

  • Published : 2013.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Colorectal cancer (CRC) exists in a more common sporadic form and less common hereditary forms, associated with the Lynch syndrome, familial adenomatous polyposis (FAP) and other rare syndromes. Sporadic CRC is believed to arise as a result of close interaction between environmental factors, including dietary and lifestyle habits, and genetic predisposition factors. In contrast, hereditary forms such as those related to the Lynch syndrome result from inheritance of germline mutations of mismatch repair (MMR) genes. However, in certain cases, the influence of low penetrance alleles in familial colorectal cancer susceptibility is also undeniable. Aim: To investigate the genotype frequencies of MLH1 promoter polymorphism -93G>A and to determine whether it could play any role in modulating familial and sporadic CRC susceptibility risk. Methods: A case-control study comprising of 104 histopathologically confirmed CRC patients as cases (52 sporadic CRC and 52 Lynch syndrome patients) and 104 normal healthy individuals as controls was undertaken. DNA was extracted from peripheral blood and the polymorphism was genotyped employing PCR-RFLP methods. The genotypes were categorized into homozygous wild type, heterozygous and homozygous variants. The risk association between these polymorphisms and CRC susceptibility risk was calculated using binary logistic regression analysis and deriving odds ratios (ORs). Results: When risk association was investigated for all CRC patients as a single group, the heterozygous (G/A) genotype showed a significantly higher risk for CRC susceptibility with an OR of 2.273, (95%CI: 1.133-4.558 and p-value=0.021). When analyzed specifically for the 2 types of CRC, the heterozygous (G/A) genotype showed significantly higher risk for sporadic CRC susceptibility with and OR of 3.714, (95%CI: 1.416-9.740 and p-value=0.008). Despite high OR value was observed for Lynch syndrome (OR: 1.600, 95%CI: 0.715-3.581), the risk was not statistically significant (P=0.253). Conclusion: Our results suggest an influence of MLH1 promoter polymorphism -93G>A in modulating susceptibility risk in Malaysian CRC patients, especially those with sporadic disease.

Keywords

References

  1. Aaltonen LA, Salovaara R, Kristo P, et al (1998). Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med, 338, 1481-7. https://doi.org/10.1056/NEJM199805213382101
  2. Allan JM, Shorto J, Adlard J, et al (2008). MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer. Int J Cancer, 123, 2456-9. https://doi.org/10.1002/ijc.23770
  3. Beiner ME, Rosen B, Fyles A, et al (2006). Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2. Cancer Epidemiol Biomarkers Prev, 15, 1636-40. https://doi.org/10.1158/1055-9965.EPI-06-0257
  4. Boland CR, Goel A (2010). Microsatellite instability in colorectal cancer. Gastroenterology, 138, 2073-87. https://doi.org/10.1053/j.gastro.2009.12.064
  5. Campbell PT, Curtin K, Ulrich CM, et al (2009). Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut, 58, 661-7. https://doi.org/10.1136/gut.2007.144220
  6. Chen H, Taylor NP, Sotamaa KM, et al (2007). Evidence for heritable predisposition to epigenetic silencing of MLH1. Int J Cancer, 120, 1684-8. https://doi.org/10.1002/ijc.22406
  7. Deng G, Chen A, Pong E, et al (2001). Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression. Oncogene, 20, 7120-7. https://doi.org/10.1038/sj.onc.1204891
  8. Dionigi G, Bianchi V, Rovera F, et al (2007). Genetic alteration in hereditary colorectal cancer. Surg Oncol, 16, 11-5. https://doi.org/10.1016/j.suronc.2007.10.020
  9. Giovannucci E (2001). An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 10, 725-31.
  10. Goh KL, Quek KF, Yeo GT, et al (2005). Colorectal cancer in Asians: a demographic and anatomic survey in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther, 22, 859-64. https://doi.org/10.1111/j.1365-2036.2005.02646.x
  11. Hampel H, Frankel W, Panescu J, et al (2006). Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res, 66, 7810-7. https://doi.org/10.1158/0008-5472.CAN-06-1114
  12. Harley I, Rosen B, Risch HA, et al (2008). Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1. Gynecol Oncol, 109, 384-7. https://doi.org/10.1016/j.ygyno.2007.11.046
  13. Ito E, Yanagisawa Y, Iwahashi Y, et al (1999). A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun, 256, 488-94. https://doi.org/10.1006/bbrc.1999.0368
  14. Jacob S, Praz F (2002). DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie, 84, 27-47. https://doi.org/10.1016/S0300-9084(01)01362-1
  15. Jass JR (2006). Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term. World J Gastroenterol, 12, 4943-50.
  16. Lagerstedt Robinson K, Liu T, Vandrovcova J, et al (2007). Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst, 99, 291-9. https://doi.org/10.1093/jnci/djk051
  17. Malaysia Cancer Statistics (2006): Data and Figures Peninsular Malaysia. IN REGISTRY, N.C. (Ed.). Kuala Lumpur.
  18. Mohd Nizam Z, Gurjeet K, Muhammad Radzi AH, et al (2011). Predominance of MLH1 -93G>A promoter polymorphism among Malaysian Lynch syndrome patients. Int Med J, 18, 268-71.
  19. Muniz-Mendoza R, Ayala-Madrigal ML, Partida-Perez M, et al (2012). MLH1 and XRCC1 polymorphisms in Mexican patients with colorectal cancer. Genet Mol Res, 11, 2315-20. https://doi.org/10.4238/2012.June.27.6
  20. Neagoe A, Molnar AM, Acalovschi M, et al (2004). Risk factors for colorectal cancer: an epidemiologic descriptive study of a series of 333 patients. Rom J Gastroenterol, 13, 187-93.
  21. Park SH, Lee GY, Jeon HS, et al (2004). -93G-->A polymorphism of hMLH1 and risk of primary lung cancer. Int J Cancer, 112, 678-82. https://doi.org/10.1002/ijc.20359
  22. Perera S, Mrkonjic M, Rawson JB, Bapat B (2011). Functional effects of the MLH1 -93G>A polymorphism on MLH1/EPM2AIP1 promoter activity. Oncol Rep, 25, 809-15.
  23. Plotz G, Zeuzem S, Raedle J (2006). DNA mismatch repair and Lynch syndrome. J Mol Histol, 37, 271-83. https://doi.org/10.1007/s10735-006-9038-5
  24. Raptis S, Mrkonjic M, Green RC, et al (2007). MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J Natl Cancer Inst, 99, 463-74. https://doi.org/10.1093/jnci/djk095
  25. Salovaara R, Loukola A, Kristo P, et al (2000). Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol, 18, 2193-200.
  26. Samowitz WS, Curtin K, Wolff RK, et al (2008). The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes Chromosomes Cancer, 47, 835-44. https://doi.org/10.1002/gcc.20584
  27. Shin KH, Shin JH, Kim JH, et al (2002). Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene. Cancer Res, 62, 38-42.
  28. Terry P, Giovannucci E, Michels KB, et al (2001). Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst, 93, 525-33. https://doi.org/10.1093/jnci/93.7.525
  29. Wong JJL, Hawkins NJ, Ward RL, Hitchins MP (2011). Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer. Modern Pathol, 24, 396-411. https://doi.org/10.1038/modpathol.2010.212
  30. Yu JH, Bigler J, Whitton J, et al (2006). Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking. Am J Gastroenterol, 101, 1313-9. https://doi.org/10.1111/j.1572-0241.2006.00551.x

Cited by

  1. Evaluation of Endoscopic Characteristics of Upper Gastrointestinal Polyps in Patients with Familial Adenomatous Polyposis vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6945
  2. Intronic and promoter polymorphisms of hMLH1/hMSH2 and colorectal cancer risk in Heilongjiang Province of China vol.141, pp.8, 2015, https://doi.org/10.1007/s00432-014-1898-6
  3. Association of DCC, MLH1, GSTT1, GSTM1, and TP53 gene polymorphisms with colorectal cancer in Kazakhstan vol.36, pp.1, 2015, https://doi.org/10.1007/s13277-014-2641-2